IRCCS Istituto Oncologico Giovanni Paolo II

Bari 70124

0 studies enrolling now · 2 studies all time

What they study most

EGFR Exon 19 Deletion, EGFR L858R, Metastatic Non Small Cell Lung Cancer, Nonsquamous Non-small Cell Lung Cancer

Studies at this site

• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling